These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12477726)

  • 21. IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2.
    Prigent M; Barlat I; Langen H; Dargemont C
    J Biol Chem; 2000 Nov; 275(46):36441-9. PubMed ID: 10969074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity.
    Schneikert J; Hübner S; Martin E; Cato AC
    J Cell Biol; 1999 Sep; 146(5):929-40. PubMed ID: 10477749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.
    Khan SH; Awasthi S; Guo C; Goswami D; Ling J; Griffin PR; Simons SS; Kumar R
    J Biol Chem; 2012 Dec; 287(53):44546-60. PubMed ID: 23132854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
    De Bosscher K; Vanden Berghe W; Haegeman G
    Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors.
    Hong H; Darimont BD; Ma H; Yang L; Yamamoto KR; Stallcup MR
    J Biol Chem; 1999 Feb; 274(6):3496-502. PubMed ID: 9920895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway.
    Kino T; Souvatzoglou E; De Martino MU; Tsopanomihalu M; Wan Y; Chrousos GP
    J Biol Chem; 2003 Jul; 278(28):25651-6. PubMed ID: 12730237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.
    Ding XF; Anderson CM; Ma H; Hong H; Uht RM; Kushner PJ; Stallcup MR
    Mol Endocrinol; 1998 Feb; 12(2):302-13. PubMed ID: 9482670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple receptor interaction domains of GRIP1 function in synergy.
    Schmidt S; Baniahmad A; Eggert M; Schneider S; Renkawitz R
    Nucleic Acids Res; 1998 Mar; 26(5):1191-7. PubMed ID: 9469826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
    Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
    J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies.
    Milovic-Holm K; Krieghoff E; Jensen K; Will H; Hofmann TG
    EMBO J; 2007 Jan; 26(2):391-401. PubMed ID: 17245429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators.
    Teyssier C; Ou CY; Khetchoumian K; Losson R; Stallcup MR
    Mol Endocrinol; 2006 Jun; 20(6):1276-86. PubMed ID: 16322096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation.
    Kayahara M; Ohanian J; Ohanian V; Berry A; Vadlamudi R; Ray DW
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1047-55. PubMed ID: 18682536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators.
    Stallcup MR; Kim JH; Teyssier C; Lee YH; Ma H; Chen D
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):139-45. PubMed ID: 12943698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling.
    Kotaja N; Vihinen M; Palvimo JJ; Jänne OA
    J Biol Chem; 2002 May; 277(20):17781-8. PubMed ID: 11893729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids.
    Subramaniam N; Treuter E; Okret S
    J Biol Chem; 1999 Jun; 274(25):18121-7. PubMed ID: 10364267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
    Wu J; Li Y; Dietz J; Lala DS
    Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.
    Kino T; Slobodskaya O; Pavlakis GN; Chrousos GP
    J Biol Chem; 2002 Jan; 277(4):2396-405. PubMed ID: 11704662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.